Centre Hospitalier Universitaire De Besancon

This study is testing whether adding a new targeted drug called MP0317 to standard chemotherapy and immunotherapy helps control advanced bile duct cancer better. The trial will include 75 patients who haven't had previous cancer treatments, with 50 receiving the experimental thre…

This study is testing whether adding an experimental cancer vaccine (UCPVax) to a standard immunotherapy drug combination (atezolizumab and bevacizumab) can better control advanced liver cancer that cannot be removed by surgery. It will involve about 105 adults with this type of …

This study is testing whether a new blood test can accurately detect colorectal cancer. Researchers want to see if this test could help identify which patients need urgent colonoscopies when healthcare systems are busy. The study involves 400 adults who either have suspected colo…

This study aims to find markers in the blood that can help doctors tell the difference between cancerous and non-cancerous growths in the pancreas. Researchers will compare blood samples from 100 people who have either a known benign pancreatic condition or a malignant tumor. The…

This small study is testing if a supervised exercise program can help people with alcohol use disorder who also have trouble sleeping. Researchers want to see if people will join and stick with the program, and if it improves their sleep quality and daily function. The results wi…

This study aims to find biological markers in the blood that can predict how well liver cancer patients respond to a specific immunotherapy combination (tremelimumab and durvalumab). Researchers will follow 120 patients with advanced liver cancer who are receiving this treatment …

This study is not testing a treatment. Its main goal is to figure out the best way to run a future, larger study on how playing video games affects sleep in adults. Researchers will test different tools like sleep trackers and questionnaires on 40 regular gamers and non-gamers to…